Sphera Funds Management Ltd. Oncorus, Inc. Transaction History

Sphera Funds Management Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.44 - $5.62 $44,562 - $173,916	-30,946 Reduced 5.42%	540,258 $962,000
Q4 2021 Feb 14, 2022	SELL	$5.03 - $11.63 $1.56 Million - $3.6 Million	-309,498 Reduced 35.14%	571,204 $3.01 Million
Q3 2021 Nov 15, 2021	SELL	$9.29 - $14.27 $119,339 - $183,312	-12,846 Reduced 1.44%	880,702 $8.23 Million
Q2 2021 Aug 17, 2021	SELL	$13.3 - $17.3 $127,187 - $165,439	-9,563 Reduced 1.06%	893,548 $12.3 Million
Q4 2020 Feb 16, 2021	BUY	$15.0 - $35.15 $13.5 Million - $31.7 Million	903,111 New	903,111 $28.4 Million

Ticker ONCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,973,100
Description
Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various canc...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.